Kris Persaud

Kris Persaud

UNVERIFIED PROFILE

Are you Kris Persaud?   Register this Author

Register author
Kris Persaud

Kris Persaud

Publications by authors named "Kris Persaud"

Are you Kris Persaud?   Register this Author

16Publications

619Reads

23Profile Views

Backbone flexibility of CDR3 and immune recognition of antigens.

J Mol Biol 2014 Apr 28;426(7):1583-99. Epub 2013 Dec 28.

Department of Biomedical Engineering, Boston University, 44 Cummington Street, Boston, MA 02215, USA; Bioinformatics Program, Boston University, 44 Cummington Street, Boston, MA 02215, USA; Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 01605, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmb.2013.12.024DOI Listing
April 2014

Development of a novel and efficient cell culture flocculation process using a stimulus responsive polymer to streamline antibody purification processes.

Biotechnol Bioeng 2013 Nov 29;110(11):2928-37. Epub 2013 Jun 29.

Bioprocess Sciences, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, 450 East 29th Street, New York, New York, 10016.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bit.24969DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812681PMC
November 2013

Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.

Cancer Res 2007 Jan;67(2):593-9

Molecular/Cancer Biology Research Program and Ludwig Institute for Cancer Research, Biomedicum Helsinki, Haartman Institute and Helsinki University Central Hospital, University of Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-3567DOI Listing
January 2007

Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.

Proc Natl Acad Sci U S A 2006 Jul 18;103(30):11405-10. Epub 2006 Jul 18.

Schepens Eye Research Institute, Harvard Medical School, 20 Staniford Street, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.0506112103
Publisher Site
http://dx.doi.org/10.1073/pnas.0506112103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1544098PMC
July 2006

Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection.

J Biol Chem 2005 Jul 4;280(28):26216-24. Epub 2005 May 4.

Division of Experimental Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M411392200DOI Listing
July 2005

A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3.

Mol Cancer Ther 2005 Mar;4(3):427-34

Department of Antibody Technology, ImClone Systems Incorporated, 180 Varick Street, New York, NY 10014, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-04-0261DOI Listing
March 2005